WealthCollab’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43K Sell
550
-238
-30% -$19.2K 0.02% 256
2026
Q1
$68.3K Hold
788
0.03% 172
2025
Q4
$75.7K Hold
788
0.03% 169
2025
Q3
$75K Buy
788
+95
+14% +$8.73K 0.03% 148
2025
Q2
$60.4K Buy
693
+20
+3% +$1.7K 0.03% 164
2025
Q1
$60.5K Buy
673
+25
+4% +$2.24K 0.04% 142
2024
Q4
$51.8K Buy
648
+9
+1% +$779 0.03% 161
2024
Q3
$57.5K Sell
639
-34
-5% -$2.86K 0.04% 149
2024
Q2
$53K Sell
673
-123
-15% -$10.1K 0.04% 149
2024
Q1
$69.4K Buy
796
+15
+2% +$1.28K 0.05% 124
2023
Q4
$64.3K Buy
+781
New +$59.5K 0.05% 122

Other funds holding MDT

WealthCollab's MDT Position: Q2 2026 in Review

WealthCollab reduced its Medtronic (MDT) stake by 30% in Q2 2026, selling an estimated $19.2K and leaving 550 shares worth $43K. The position accounts for 0.02% of the portfolio, ranked #256.

WealthCollab first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $75.7K in Q4 2025. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • WealthCollab held 550 shares of Medtronic worth $43K as of Q2 2026.
  • WealthCollab sold 238 Medtronic shares in Q2 2026, an estimated $19.2K.
  • Medtronic made up 0.02% of WealthCollab's portfolio in Q2 2026, its #256 holding.
  • WealthCollab first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • WealthCollab's Medtronic position peaked at $75.7K in Q4 2025.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.